We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.51%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3B
AUM Growth
-$104M
(-3.3%)
Cap. Flow
-$35.7M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
32.3%
Holding
3,551
New
192
Increased
1,348
Reduced
1,018
Closed
188
Avg Time Held Equity + Options
3.8
years
Top 10 Avg Time Held Equity + Options
2.3
years
Top 20 Avg Time Held Equity + Options
2.6
years
Avg Time Held Equity only
3.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$38.1M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$12.4M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$5.32M |
| 4 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$4.9M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares International Select Dividend ETF
IDV
|
+$46.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.4M |
| 3 |
SPDR Gold Trust
GLD
|
+$19M |
| 4 |
CVB Financial
CVBF
|
+$14.9M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$5.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.33% |
| 2 | Technology | 15.36% |
| 3 | Healthcare | 9.27% |
| 4 | Financials | 6.89% |
| 5 | Consumer Discretionary | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
ARS Pharmaceuticals
SPRY
$400M
| $571 | ﹤0.01% |
+151
| New | +$991 |
2023 Q3
0 quarters
|
|
3077
Agios Pharmaceuticals
AGIO
$1.87B
| $569 | ﹤0.01% |
23
| – | – |
2023 Q2
1 quarter
|
|
3078
ProShares Ultra Bloomberg Crude Oil
UCO
$489M
| $564 | ﹤0.01% |
16
| – | – |
2020 Q2
13 quarters
|
|
3079
Neostellar Capital Corp
NSLR
$169M
| $561 | ﹤0.01% |
155
| – | – |
2021 Q3
8 quarters
|
|
3080
DELISTED
Lakeland Bancorp Inc
LBAI
| $559 | ﹤0.01% |
44
+18
| +69% | +$249 |
2020 Q2
13 quarters
|
|
3081
Arlo Technologies
ARLO
$1.31B
| $556 | ﹤0.01% |
54
| – | – |
2022 Q4
3 quarters
|
|
3082
Gogo Inc
GOGO
$289M
| $549 | ﹤0.01% |
46
+27
| +142% | +$373 |
2022 Q2
5 quarters
|
|
3083
Wave Life Sciences
WVE
$617M
| $546 | ﹤0.01% |
95
| – | – |
2023 Q1
2 quarters
|
|
3084
Frontline
FRO
$11.7B
| $545 | ﹤0.01% |
29
| – | – |
2022 Q2
5 quarters
|
|
3085
SoFi Social 50 ETF
SFYF
$42.4M
| $545 | ﹤0.01% |
20
| – | – |
2021 Q4
7 quarters
|
|
|
CBD
3086
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $545 | ﹤0.01% |
817
| – | – |
2023 Q1
2 quarters
|
|
3087
Levi Strauss
LEVI
$7.84B
| $543 | ﹤0.01% |
40
-6
| -13% | -$84 |
2023 Q2
1 quarter
|
|
3088
Digi International
DGII
$2.65B
| $540 | ﹤0.01% |
20
| – | – |
2022 Q3
4 quarters
|
|
3089
Bristow Group
VTOL
$1.15B
| $535 | ﹤0.01% |
19
-5
| -21% | -$145 |
2021 Q4
7 quarters
|
|
3090
Kura Sushi USA
KRUS
$463M
| $529 | ﹤0.01% |
8
| – | – |
2023 Q1
2 quarters
|
|
3091
Glaukos
GKOS
$9.72B
| $527 | ﹤0.01% |
7
| – | – |
2021 Q4
7 quarters
|
|
3092
AngioDynamics
ANGO
$473M
| $526 | ﹤0.01% |
72
| – | – |
2020 Q1
14 quarters
|
|
3093
Distribution Solutions Group
DSGR
$1.62B
| $520 | ﹤0.01% |
20
| – | – |
2022 Q3
4 quarters
|
|
3094
Grid Dynamics Holdings
GDYN
$632M
| $512 | ﹤0.01% |
+42
| New | +$466 |
2023 Q3
0 quarters
|
|
3095
RUM Group Inc
RUM
$2.28B
| $510 | ﹤0.01% |
100
| – | – |
2022 Q3
4 quarters
|
|
3096
Veeco
VECO
$2.61B
| $506 | ﹤0.01% |
18
| – | – |
2023 Q2
1 quarter
|
|
3097
Axogen
AXGN
$2.03B
| $500 | ﹤0.01% |
100
| – | – |
2022 Q3
4 quarters
|
|
3098
Upwork
UPWK
$1.05B
| $500 | ﹤0.01% |
44
| – | – |
2020 Q2
13 quarters
|
|
3099
Horace Mann Educators
HMN
$1.88B
| $499 | ﹤0.01% |
17
| – | – |
2021 Q1
10 quarters
|
|
3100
Inovio Pharmaceuticals
INO
$102M
| $498 | ﹤0.01% |
+107
| New | +$591 |
2023 Q3
0 quarters
|
|
Similar funds
Parallel Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Parallel Advisors held 3,551 positions worth $3B, down 3.3% from $3.11B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q3 2023 filing shows 192 new, 1,348 increased, 1,018 reduced and 188 closed positions. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M. The largest sale was iShares International Select Dividend ETF, an estimated $46.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q3 2023 buy was iShares MSCI Intl Quality Factor ETF: 96,005 shares worth $3.23M.
- Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q3 2023, an estimated $38.1M increase.
- Parallel Advisors's biggest Q3 2023 reduction was iShares International Select Dividend ETF, cutting an estimated $46.2M.
- Parallel Advisors fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $244K.
- Parallel Advisors's ten largest holdings make up 32% of its $3B portfolio in Q3 2023.
- Parallel Advisors opened 192 new positions and closed 188 in Q3 2023.
- Parallel Advisors's portfolio value fell 3.3% quarter-over-quarter to $3B.
Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.